Molecular Evolution of Human Parainfluenza Virus Type 2 Based on Hemagglutinin-Neuraminidase Gene. 2023

Yi Feng, and Zhen Zhu, and Jin Xu, and Liwei Sun, and Hui Zhang, and Hongmei Xu, and Feng Zhang, and Wenyang Wang, and Guangyue Han, and Jie Jiang, and Ying Liu, and Shanshan Zhou, and Yan Zhang, and Yixin Ji, and Naiying Mao, and Wenbo Xu
National Health Commission (NHC) Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.

To understand the molecular evolution of human parainfluenza virus type 2 (HPIV2), 21 Hemagglutinin-Neuraminidase (HN) gene sequences covering seven Chinese provinces in 2011 and 2017 to 2021 were combined with 90 published HN sequences worldwide for phylogenetic analysis. The result showed that global HPIV2 could be classified into two distinct clusters (I and II), five lineages (IA to IIE), and four sublineages (IB1 and 2, and IIE1 and 2). The minimum genetic distances between different clusters and lineages were 0.049 and 0.014, respectively. In the last decade, one lineage (IID) and three sublineages (IB1, IB2, and IIE1) have been cocirculating in China, with the sublineages IB2 and IIE1 dominating, while sublineages IB1 and IIE1 are dominant globally. In addition, the spread of HPIV2 had relative spatial clustering, and sublineage IB2 has only been detected in China thus far. The overall evolution rate of HPIV2 was relatively low, on the order of 10-4 substitutions/site/year, except for sublineage IB2 at 10-3 substitutions/site/year. Furthermore, human-animal transmission was observed, suggesting that the HPIV2 might have jumped out of animal reservoirs in approximately 1922, the predicted time of a common ancestor. The entire HN protein was under purifying/negative selection, and the specific amino acid changes and two novel N-glycosylation sites (N316 and N517) in sublineages IB1, IB2, and IIE1 were mostly located in the globular head region of the HN protein. In this study, preliminary evolutionary characteristics of HPIV2 based on the HN gene were obtained, increasing the recognition of the evolution and adaptation of HPIV2. IMPORTANCE The phylogenetic analysis showed that global HPIV2 could be classified into two distinct clusters (I and II) and five lineages (IA to IIE) with at least 0.049 and 0.014 genetic distances between clusters and lineages, respectively. Furthermore, lineages IB and IIE could be further divided into two sublineages (IB1-2 and IIE1-2). All China sequences belong to one lineage and three sublineages (IB1, IB2, IID, and IIE1), among which sublineages IB2 and IIE1 are predominant and cocirculating in China, while sublineages IB1 and IIE1 are dominant globally. The overall evolution rate of HPIV2 is on the order of 10-4 substitutions/site/year, with the highest rate of 2.18 × 10-3 for sublineage IB2. The entire HN protein is under purifying/negative selection, and the specific amino acid substitutions and two novel N-glycosylation sites (N316 and N517) in sublineages IB1, IB2, and IIE1 are mostly located in the globular head region of the HN protein.

UI MeSH Term Description Entries
D009439 Neuraminidase An enzyme that catalyzes the hydrolysis of alpha-2,3, alpha-2,6-, and alpha-2,8-glycosidic linkages (at a decreasing rate, respectively) of terminal sialic residues in oligosaccharides, glycoproteins, glycolipids, colominic acid, and synthetic substrate. (From Enzyme Nomenclature, 1992) Sialidase,Exo-alpha-Sialidase,N-Acylneuraminate Glycohydrolases,Oligosaccharide Sialidase,Exo alpha Sialidase,Glycohydrolases, N-Acylneuraminate,N Acylneuraminate Glycohydrolases,Sialidase, Oligosaccharide
D010223 Parainfluenza Virus 2, Human A species of RUBULAVIRUS associated particularly with acute laryngotracheitis (CROUP) in children aged 6 months to 3 years. Acute Laryngotracheobronchitis Virus,Croup-Associated Virus,Human parainfluenza virus 2,Acute Laryngotracheo-Bronchitis Virus,Croup-Associated Viruses,Para-Influenza Virus Type 2,Parainfluenza Virus Type 2,Virus, Croup-Associated,Viruses, Croup-Associated,Acute Laryngotracheo-Bronchitis Viruses,Acute Laryngotracheobronchitis Viruses,Croup Associated Virus,Croup Associated Viruses,Laryngotracheo-Bronchitis Virus, Acute,Laryngotracheo-Bronchitis Viruses, Acute,Laryngotracheobronchitis Virus, Acute,Laryngotracheobronchitis Viruses, Acute,Para Influenza Virus Type 2
D010802 Phylogeny The relationships of groups of organisms as reflected by their genetic makeup. Community Phylogenetics,Molecular Phylogenetics,Phylogenetic Analyses,Phylogenetic Analysis,Phylogenetic Clustering,Phylogenetic Comparative Analysis,Phylogenetic Comparative Methods,Phylogenetic Distance,Phylogenetic Generalized Least Squares,Phylogenetic Groups,Phylogenetic Incongruence,Phylogenetic Inference,Phylogenetic Networks,Phylogenetic Reconstruction,Phylogenetic Relatedness,Phylogenetic Relationships,Phylogenetic Signal,Phylogenetic Structure,Phylogenetic Tree,Phylogenetic Trees,Phylogenomics,Analyse, Phylogenetic,Analysis, Phylogenetic,Analysis, Phylogenetic Comparative,Clustering, Phylogenetic,Community Phylogenetic,Comparative Analysis, Phylogenetic,Comparative Method, Phylogenetic,Distance, Phylogenetic,Group, Phylogenetic,Incongruence, Phylogenetic,Inference, Phylogenetic,Method, Phylogenetic Comparative,Molecular Phylogenetic,Network, Phylogenetic,Phylogenetic Analyse,Phylogenetic Clusterings,Phylogenetic Comparative Analyses,Phylogenetic Comparative Method,Phylogenetic Distances,Phylogenetic Group,Phylogenetic Incongruences,Phylogenetic Inferences,Phylogenetic Network,Phylogenetic Reconstructions,Phylogenetic Relatednesses,Phylogenetic Relationship,Phylogenetic Signals,Phylogenetic Structures,Phylogenetic, Community,Phylogenetic, Molecular,Phylogenies,Phylogenomic,Reconstruction, Phylogenetic,Relatedness, Phylogenetic,Relationship, Phylogenetic,Signal, Phylogenetic,Structure, Phylogenetic,Tree, Phylogenetic
D002583 Uterine Cervical Neoplasms Tumors or cancer of the UTERINE CERVIX. Cancer of Cervix,Cancer of the Cervix,Cancer of the Uterine Cervix,Cervical Cancer,Cervical Neoplasms,Cervix Cancer,Cervix Neoplasms,Neoplasms, Cervical,Neoplasms, Cervix,Uterine Cervical Cancer,Cancer, Cervical,Cancer, Cervix,Cancer, Uterine Cervical,Cervical Cancer, Uterine,Cervical Cancers,Cervical Neoplasm,Cervical Neoplasm, Uterine,Cervix Neoplasm,Neoplasm, Cervix,Neoplasm, Uterine Cervical,Uterine Cervical Cancers,Uterine Cervical Neoplasm
D005260 Female Females
D006388 Hemagglutinins Agents that cause agglutination of red blood cells. They include antibodies, blood group antigens, lectins, autoimmune factors, bacterial, viral, or parasitic blood agglutinins, etc. Isohemagglutinins,Exohemagglutinins,Hemagglutinin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014764 Viral Proteins Proteins found in any species of virus. Gene Products, Viral,Viral Gene Products,Viral Gene Proteins,Viral Protein,Protein, Viral,Proteins, Viral
D015707 HN Protein Glycoprotein from Sendai, para-influenza, Newcastle Disease, and other viruses that participates in binding the virus to cell-surface receptors. The HN protein possesses both hemagglutinin and neuraminidase activity. Hemagglutinin-Neuraminidase Glycoprotein,HANA Glycoprotein,HN Glycoprotein, Sendai Virus,Glycoprotein, HANA,Glycoprotein, Hemagglutinin-Neuraminidase,Hemagglutinin Neuraminidase Glycoprotein,Protein, HN

Related Publications

Yi Feng, and Zhen Zhu, and Jin Xu, and Liwei Sun, and Hui Zhang, and Hongmei Xu, and Feng Zhang, and Wenyang Wang, and Guangyue Han, and Jie Jiang, and Ying Liu, and Shanshan Zhou, and Yan Zhang, and Yixin Ji, and Naiying Mao, and Wenbo Xu
April 1990, Virus research,
Yi Feng, and Zhen Zhu, and Jin Xu, and Liwei Sun, and Hui Zhang, and Hongmei Xu, and Feng Zhang, and Wenyang Wang, and Guangyue Han, and Jie Jiang, and Ying Liu, and Shanshan Zhou, and Yan Zhang, and Yixin Ji, and Naiying Mao, and Wenbo Xu
January 2015, Intervirology,
Yi Feng, and Zhen Zhu, and Jin Xu, and Liwei Sun, and Hui Zhang, and Hongmei Xu, and Feng Zhang, and Wenyang Wang, and Guangyue Han, and Jie Jiang, and Ying Liu, and Shanshan Zhou, and Yan Zhang, and Yixin Ji, and Naiying Mao, and Wenbo Xu
October 1997, The Journal of infectious diseases,
Yi Feng, and Zhen Zhu, and Jin Xu, and Liwei Sun, and Hui Zhang, and Hongmei Xu, and Feng Zhang, and Wenyang Wang, and Guangyue Han, and Jie Jiang, and Ying Liu, and Shanshan Zhou, and Yan Zhang, and Yixin Ji, and Naiying Mao, and Wenbo Xu
November 2012, Journal of the American Chemical Society,
Yi Feng, and Zhen Zhu, and Jin Xu, and Liwei Sun, and Hui Zhang, and Hongmei Xu, and Feng Zhang, and Wenyang Wang, and Guangyue Han, and Jie Jiang, and Ying Liu, and Shanshan Zhou, and Yan Zhang, and Yixin Ji, and Naiying Mao, and Wenbo Xu
September 2008, Journal of virology,
Yi Feng, and Zhen Zhu, and Jin Xu, and Liwei Sun, and Hui Zhang, and Hongmei Xu, and Feng Zhang, and Wenyang Wang, and Guangyue Han, and Jie Jiang, and Ying Liu, and Shanshan Zhou, and Yan Zhang, and Yixin Ji, and Naiying Mao, and Wenbo Xu
November 1992, The Journal of infectious diseases,
Yi Feng, and Zhen Zhu, and Jin Xu, and Liwei Sun, and Hui Zhang, and Hongmei Xu, and Feng Zhang, and Wenyang Wang, and Guangyue Han, and Jie Jiang, and Ying Liu, and Shanshan Zhou, and Yan Zhang, and Yixin Ji, and Naiying Mao, and Wenbo Xu
October 2001, Journal of virological methods,
Yi Feng, and Zhen Zhu, and Jin Xu, and Liwei Sun, and Hui Zhang, and Hongmei Xu, and Feng Zhang, and Wenyang Wang, and Guangyue Han, and Jie Jiang, and Ying Liu, and Shanshan Zhou, and Yan Zhang, and Yixin Ji, and Naiying Mao, and Wenbo Xu
June 1985, Virology,
Yi Feng, and Zhen Zhu, and Jin Xu, and Liwei Sun, and Hui Zhang, and Hongmei Xu, and Feng Zhang, and Wenyang Wang, and Guangyue Han, and Jie Jiang, and Ying Liu, and Shanshan Zhou, and Yan Zhang, and Yixin Ji, and Naiying Mao, and Wenbo Xu
February 2012, Glycobiology,
Yi Feng, and Zhen Zhu, and Jin Xu, and Liwei Sun, and Hui Zhang, and Hongmei Xu, and Feng Zhang, and Wenyang Wang, and Guangyue Han, and Jie Jiang, and Ying Liu, and Shanshan Zhou, and Yan Zhang, and Yixin Ji, and Naiying Mao, and Wenbo Xu
January 1964, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
Copied contents to your clipboard!